Diabetic neuropathies: Clinical manifestations and current treatment options

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 5, 2006, Pages 269-281

  Vinik, Aaron ^a,b,c   Ullal, Jagdeesh ^b   Parson, Henri K ^b   Casellini, Carolina M ^b  

^a Department of Internal Medicine Pathology Neurobiology ^*  (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Strelitz Diabetes Research Institutes   (United States)

Author keywords

Diabetes mellitus; Diabetic autonomic neuropathy; Diabetic neuropathy; Pain; Treatment

Indexed keywords

AMPUTATION; ATAXIA; AUTONOMIC NERVOUS SYSTEM; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DIABETIC NEUROPATHY; FALLING; FRACTURE; GANGRENE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; METABOLIC SYNDROME X; NERVE FIBER; NERVE INJURY; PARESTHESIA; PATIENT EDUCATION; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

ANTIDEPRESSIVE AGENTS; DIABETIC NEUROPATHIES; HUMANS; HYPOGLYCEMIC AGENTS; MODELS, BIOLOGICAL; PALLIATIVE CARE; QUALITY OF LIFE;

EID: 33646587366     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0142     Document Type: Review

References (79)

1. Caputo GM et al. (1994) Assessment and management of foot disease in patients with diabetes. N Engl J Med 331: 854-860
2. Vinik E et al. (2005) The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 7: 497-508
3. Vinik AI (2004) Advances in diabetes for the millennium: new treatments for diabetic neuropathies. MedGenMed 6 (3 Suppl): 13
4. Boulton A et al. (2004) Diabetic somatic neuropathies. Diabetes Care 27: 1458-1486
5. Dyck PJ (2003) Severity and staging of diabetic polyneuropathy. In Textbook of Diabetic Neuropathy, 170-175 (Eds Gries FA et al.) Stuttgart: Thieme
6. Thomas PK (1997) Classification, differential diagnosis and staging of diabetic peripheral neuropathy. Diabetes 46 (Suppl 2): S54-S57
7. Boulton AJ et al. (2005) Position statement: diabetic neuropathies. Diabetes Care 28: 956-962
8. Vinik A and Mehrabyan A (2004) Diabetic neuropathies. Med Clin North Am 88: 947-999
9. Oyibo SO et al. (2002) The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 19: 870-873
10. Tesfaye S et al. (1996) Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycemic control (insulin neuritis). Diabetologia 39: 329-335
11. Sinnreich M et al. (2005) Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist 11: 63-79
12. Harris M et al. (1993) Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 16: 1446-1452
13. Singleton JR et al. (2001) Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24: 1225-1228
14. Singleton JR et al. (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24: 1448-1453
15. Sumner C et al. (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108-111
16. Cavanagh PR et al. (1993) Ulceration, unsteadiness, and uncertainty: the biomechanical consequences of diabetes mellitus. J Biomech 26 (Suppl 1): 23-40
17. Katoulis EC et al. (1997) Gait abnormalities in diabetic neuropathy. Diabetes Care 20: 1904-1907
18. Dyck PJ et al. (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43: 817-824
19. Dyck PJ (1988) Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11: 21-32
20. Vinik AI et al. (1995) Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 18: 574-584
21. Abbott CA et al. (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19: 377-384
22. Dyck PJ et al. (1997) Approaches to improve epidemiological studies of diabetic neuropathy: insights from the Rochester Diabetic Neuropathy Study. Diabetes 46 (Suppl 2): S5-S8
23. Yarnitsky D and Sprecher E (1994) Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 125: 39-45
24. Anonymous (1988) Consensus Statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology. Diabetes Care 11: 592-597
25. Anonymous (1995) Peripheral Nerve Society. Diabetic polyneuropathy in controlled clinical trials: consensus report of the Peripheral Nerve Society. Ann Neurol 38: 478-482
26. Partanen J et al. (1995) Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333: 89-94
27. DCCT Research Group (1995) The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122: 561-568
28. Vinik A et al. (2004) Focal entrapment neuropathies in diabetes. Diabetes Care 27: 1783-1788
29. Kennedy WR et al. (1996) Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47: 1042-1048
30. Polydefkis M et al. (2001) Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 3: 23-28
31. Pittenger G et al. (2004) Intraepidermal nerve fibers are indicators of small fiber neuropathy in both diabetic and non-diabetic patients. Diabetes Care 27: 1974-1979
32. Vileikyte L et al. (2003) The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care 26: 2549-2555
33. Maser RE et al. (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26: 1895-1901
34. Ziegler D et al. (1992)The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications 6: 49-57
35. Vinik AI et al. (2003) Diabetic autonomic neuropathy. Diabetes Care 26: 1553-1579
36. Ziegler D and Gries FA (1997) α-Lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 46 (Suppl 2): S62-S66
37. Athyros VG et al. (1998) Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. Acta Cardiol 53: 201-209
38. Gaede P et al. (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomized study. Lancet 353: 617-622
39. Wilbourn AJ (1999) Diabetic entrapment and compression neuropathies. In Diabetic Neuropathy, 481-508 (Eds Dyck PJ and Thomas PK) Philadelphia: Saunders
40. Watanabe K et al. (1990) Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 10: 19-27
41. Perkins B et al. (2002) Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 25: 565-569
42. Dyck PJ and Windebank AJ (2002) Diabetic and nondiabetic lumbosacral radiculoplexus neuropathy: new insights into pathophysiology and treatment. Muscle Nerve 25: 477-491
43. Sharma K et al. (2002) Demyelinating neuropathy in diabetes mellitus. Arch Neurol 59: 758-765
44. Krendel DA et al. (1997) Autoimmune diabetic neuropathy. Neurol Clin 15: 959-971
45. Ayyar DR and Sharma KR (2004) Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus. Curr Diab Rep 4: 409-412
46. DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977-986
47. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703-713
48. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-865
49. Gaede P et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383-393
50. Tesfaye S et al. (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352: 341-350
51. Ziegler D et al. (2004) Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 27: 2178-2183
52. Vincent AM et al. (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25: 612-628
53. Bril V and Buchanan RA (2004) Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy. Diabetes Care 27: 2369-2375
54. Keen H et al. (1993) Treatment of diabetic neuropathy with γ-linolenic acid. The γ-Linolenic Acid Multicenter Trial Group. Diabetes Care 16: 8-15
55. Ziegler D et al. (2004) Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid: a meta-analysis. Diabet Med 21: 114-121
56. Vinik A et al. (2005) Sural sensory nerve action potential identifies diabetic peripheral neuropathy responders to therapy. Muscle Nerve 32: 619-625
57. Vinik A et al. (2005) Treatment of symptomatic diabetic peripheral neuropathy with protein kinase CB inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Ther 27: 1164-1180
58. Pittenger G and Vinik A (2003) Nerve growth factor and diabetic neuropathy Exp Diabesity Res 4: 271-285
59. Vinik AI (1999) Treatment of diabetic polyneuropathy (DPN) with recombinant human nerve growth factor (rhNGF). In National Diabetes Association, 59th Scientific Sessions: 1999, June 19-22; San Diego, CA, 48: 0232:A54
60. Rivard A et al. (1999) Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154: 355-363
61. Milicevic Z et al. (1997) Anti-ganglioside GM1 antibody and distal symmetric "diabetic polyneuropathy" with dominant motor features. Diabetologia 40: 1364-1365
62. Vinik AI et al. (2005) Antibodies to neuronal structures: innocent bystanders or neurotoxins? Diabetes Care 28: 2067-2072
63. Granberg V et al. (2005) Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. Diabetes Care 28: 1959-1964
64. Krendel DA et al. (1995) Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 52: 1053-1061
65. Rains C and Bryson HM (1995) Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7: 317-328
66. Goldstein DJ et al. (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116: 109-118
67. Rosenstock J et al. (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110: 628-638
68. Said G et al. (1998) Uncommon early-onset neuropathy in diabetic patients. J Neurol 245: 61-68
69. Harati Y et al. (1998) Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50: 1842-1846
70. Dworkin RH et al. (2003) Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60: 1524-1534
71. Sindrup S et al. (1990) The selective serotonin reuptake inhibitor paroxetine is effective in treatment of diabetic neuropathy symptoms. Pain 42: 135-144
72. Goldstein DJ et al. (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116: 109-118
73. Backonja M et al. (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280: 1831-1836
74. DeToledo JC et al. (1997) Changes in body weight with chronic, high-dose gabapentin therapy. Ther Drug Monit 19: 394-396
75. Raskin P et al. (2004) Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63: 865-873
76. Vinik A (2005) Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 90: 4936-4945
77. Cavanagh PR et al. (1992) Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med 9: 469-474
78. Liu-Ambrose T et al. (2004) Resistance and agility training reduce fall risk in women aged 75 to 85 with low bone mass: a 6-month randomized, controlled trial. J Am Geriatr Soc 52: 657-665
79. Jude EB et al. (2001) Biphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomized controlled trial. Diabetologia 44: 2032-2037